SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 129 filers reported holding SCICLONE PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $576,000 | +12.1% | 52,400 | 0.0% | 0.01% | +16.7% |
Q1 2017 | $514,000 | -9.2% | 52,400 | 0.0% | 0.01% | -14.3% |
Q4 2016 | $566,000 | +31.0% | 52,400 | +24.5% | 0.01% | +16.7% |
Q3 2016 | $432,000 | -22.4% | 42,100 | -1.3% | 0.01% | -33.3% |
Q2 2016 | $557,000 | -8.2% | 42,650 | -22.7% | 0.01% | -10.0% |
Q1 2016 | $607,000 | -70.9% | 55,150 | -75.7% | 0.01% | -74.4% |
Q4 2015 | $2,088,000 | +43.1% | 226,950 | +7.9% | 0.04% | +25.8% |
Q3 2015 | $1,459,000 | -10.9% | 210,250 | +26.2% | 0.03% | -3.1% |
Q2 2015 | $1,637,000 | +10.8% | 166,650 | 0.0% | 0.03% | +3.2% |
Q1 2015 | $1,477,000 | +1.2% | 166,650 | 0.0% | 0.03% | -6.1% |
Q4 2014 | $1,460,000 | +27.2% | 166,650 | 0.0% | 0.03% | +13.8% |
Q3 2014 | $1,148,000 | +30.9% | 166,650 | 0.0% | 0.03% | +26.1% |
Q2 2014 | $877,000 | +19.2% | 166,650 | +3.0% | 0.02% | +9.5% |
Q1 2014 | $736,000 | +30.7% | 161,750 | +44.7% | 0.02% | +23.5% |
Q4 2013 | $563,000 | -0.7% | 111,750 | 0.0% | 0.02% | -10.5% |
Q3 2013 | $567,000 | – | 111,750 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sensato Investors LLC | 1,564,682 | $10,859,000 | 2.03% |
Matarin Capital Management, LLC | 274,291 | $1,903,580,000 | 0.39% |
AMERICAFIRST CAPITAL MANAGEMENT, LLC | 87,524 | $607,417,000 | 0.36% |
TFS CAPITAL LLC | 323,415 | $2,245,000 | 0.22% |
Nantahala Capital Management | 170,218 | $1,181,000 | 0.16% |
Ativo Capital Management LLC | 74,338 | $592,000 | 0.16% |
MENTA CAPITAL LLC | 111,985 | $777,000 | 0.12% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 229,891 | $1,595,000 | 0.11% |
GSA CAPITAL PARTNERS LLP | 270,888 | $1,880,000 | 0.09% |
BOOTHBAY FUND MANAGEMENT, LLC | 25,644 | $178,000 | 0.08% |